International Patent: USE OF RECOMBINANT ADENO-ASSOCIATED VIRUS EXPRESSING RS1 PROTEIN IN PREPARATION OF ANTI-X-LINKED JUVENILE RETINOSCHISIS DRUG

GENEVA, Aug. 31 -- WUHAN GENEVECTOR BIOTECHNOLOGY CO., LTD. filed a patent application (CN2025/078971) for “USE OF RECOMBINANT ADENO-ASSOCIATED VIRUS EXPRESSING RS1 PROTEIN IN PREPARATION OF ANTI-X-LINKED JUVENILE RETINOSCHISIS DRUG”. With publication no. WO/2026/174608, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 48/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....